Renibus Therapeutics Announces $47 Million Financing to Advance Lead Program RBT-1 Through Pivotal Phase 3 Trial
Financing follows positive final Phase 2 results of RBT-1 presented at AATS 2023
Proceeds fund pivotal Phase 3 trial of RBT-1; on track to initiate in Q3 2023
SOUTHLAKE, Texas, July 18, 2023 -- (Healthcare Sales & Marketing Network) -- Renibus Thera... Biopharmaceuticals, Venture Capital Renibus Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 18, 2023 Category: Pharmaceuticals Source Type: news
Flagship Pioneering and Pfizer Partner to Accelerate Development of Innovative Medicines Targeting Unmet Needs
Flagship Pioneering and Pfizer to invest a total of $100M upfront to explore opportunities to develop 10 single-asset programs within Pfizer's core strategic areas of interest and addressing unmet needs, including in broad patient populations
Pioneering... Biopharmaceuticals Flagship Pioneering, Pfizer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 18, 2023 Category: Pharmaceuticals Source Type: news
Getinge recieves US FDA 510(k) clearance for Servo-air(R) Lite
Getinge announces clearance from the US FDA for Servo-air® Lite, a wall gas independent non-invasive mechanical ventilator.
GOTHENBURG, Sweden, July 7, 2023 -- (Healthcare Sales & Marketing Network) -- "We are happy to broaden our ventilator p... Devices, FDA Getinge, Servo-air Lite, ventilator (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 17, 2023 Category: Pharmaceuticals Source Type: news
ViewRay(R) Files Voluntary Chapter 11 Petitions
Debtor-in-Possession Financing Secured to Support Ongoing Operations and Chapter 11 Process
DENVER, July 17, 2023 -- (Healthcare Sales & Marketing Network) -- ViewRay, Inc. (Nasdaq: VRAY) announced today that it and certain of its subsidiaries (collect... Devices, Oncology ViewRay, MRIdian, MRI-guided radiation therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 17, 2023 Category: Pharmaceuticals Source Type: news
RaySearch releases RayCare 2023B
RaySearch Laboratories AB (publ) announces the release of the latest version of RayCare®*, the next generation oncology information system. RayCare® 2023B* features a deeper and richer integration between RaySearch's products than ever before and i... Devices, Oncology, Product Launch RaySearch Laboratories, RayCare, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 14, 2023 Category: Pharmaceuticals Source Type: news
Elevation Oncology Appoints Joseph Ferra as Chief Executive Officer and Promotes Tammy Furlong to Chief Financial Officer
NEW YORK, July 13, 2023 -- (Healthcare Sales & Marketing Network) -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid t... Biopharmaceuticals, Oncology, Personnel Elevation Oncology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 13, 2023 Category: Pharmaceuticals Source Type: news
BrainStorm Cell Therapeutics Appoints Bob Dagher, M.D., as Executive Vice President and Chief Development Officer
Dr. Dagher has extensive biopharma industry expertise in the development and approval of treatments for challenging neurological and rare diseases
NEW YORK, July 12, 2023 -- (Healthcare Sales & Marketing Network) -- BrainStorm Cell Therapeutics Inc. (N... Regenerative Medicine, Personnel BrainStorm Cell Therapeutics, NurOwn, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 12, 2023 Category: Pharmaceuticals Source Type: news
Southwest Florida Proton selects RayStation
RaySearch Laboratories AB (publ) announces that Southwest Florida Proton, USA, has placed an order for the treatment planning system RayStation®* to be installed at its new proton center in Estero, Florida.
STOCKHOLM, July 12, 2023 -- (Healthcare Sa... Devices, Oncology RaySearch Laboratories, proton therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 12, 2023 Category: Pharmaceuticals Source Type: news
GI Dynamics Announces Company Rebrand as Morphic Medical(R) Reintroducing Flagship Product as RESET(R)
BOSTON, July 11, 2023 -- (Healthcare Sales & Marketing Network) -- GI Dynamics, creator of the world's first medical device designed to target the underlying cause of type 2 diabetes, is proud to announce its rebrand to Morphic Medical and the introductio... Devices, Endocrinology Morphic Medical, GI Dynamics, EndoBarrier, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 11, 2023 Category: Pharmaceuticals Source Type: news
RayCare in clinical use with CyberKnife at Lausanne University Hospital (CHUV) in Switzerland
RaySearch Laboratories AB (publ) announces that Lausanne Univeristy Hospital (CHUV), Switzerland, has treated their first patient using RayStation®* treatment planning system together with the oncology information system RayCare®* in combination wi... Devices, Oncology RaySearch Laboratories, Accuray, CyberKnife, RayStation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 10, 2023 Category: Pharmaceuticals Source Type: news
PainTEQ Raises $35 Million in Non-Dilutive IP-Backed Financing, Fueling Market Expansion and Innovation
TAMPA, Fla., July 10, 2023 -- (Healthcare Sales & Marketing Network) -- PainTEQ, a market leader in minimally invasive posterior sacroiliac (SI) joint fusion procedures, today announced the closing of $35 million in non-dilutive growth capital backed by i... Devices, Orthopaedic, Neurosurgery, Venture Capital PainTEQ, LinQ , SI joint, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 10, 2023 Category: Pharmaceuticals Source Type: news
Append Medical Raises $4.35M in Initial Closing of Extended Series A Round
Funds will be used to complete the development of and support the First-in-Human Study of the Appligator™ for the Prevention of Stroke in Atrial Fibrillation Patients
OR YEHUDA, Israel, July 6, 2023 -- (Healthcare Sales & Marketing Network) -- Append M... Devices, Interventional, Cardiology, Venture Capital Append Medical, Appligator, left atrial appendage, Atrial Fibrillation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 6, 2023 Category: Pharmaceuticals Source Type: news
Abbott Receives FDA Approval for World's First Dual Chamber Leadless Pacemaker
Abbott's breakthrough technology enables the world's first beat-to-beat, wireless communication and synchronization between two leadless pacemakers, which are smaller than a AAA battery
Leadless pacemakers provide a new minimally invasive option that wi... Devices, Cardiology, FDA Abbott, AVEIR DR, leadless pacemaker, pacemaker (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 5, 2023 Category: Pharmaceuticals Source Type: news
Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration
SHANGHAI and BOSTON, July 3, 2023 -- (Healthcare Sales & Marketing Network) -- Skyline Therapeutics, an innovation-driven gene therapy company committed to developing unique and novel solutions for rare and severe diseases, today announced that the U.S. F... Regenerative Medicine, Ophthalmology, FDA Skyline Therapeutics, macular degeneration, gene therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 3, 2023 Category: Pharmaceuticals Source Type: news
Shane Brown Promoted to President of GT Medical Technologies, Inc.
TEMPE, Ariz., June 29, 2023 -- (Healthcare Sales & Marketing Network) -- GT Medical Technologies, Inc. the provider of GammaTile® Therapy for the treatment of patients with operable brain tumors, has announced the promotion of Shane Brown to the posit... Devices, Oncology, Personnel GT Medical Technologies, GammaTile, brain tumor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 29, 2023 Category: Pharmaceuticals Source Type: news
